Erick Grana, MD
Erick Grana, MD
Dr. Grana is a physiatrist and pain management specialist with extensive clinical experience. After earning his Doctor of Medicine degree (M.D.) and completing a residence program in Physical Medicine and Rehabilitation, Dr. Grana completed a fellowship training at the university of Washington. Dr. Grana’s background includes academic medicine, as past assistant professor at Baylor College of Medicine in Houston, Texas. He also has worked as attending physician at the V.A. Hospital in Houston. He moved to Tampa, Florida 20 years ago and started a successful pain management practice.
Dr Grana has performed more than 10,000 joint and tendon injections, and more than 15,000 spinal procedures. He is also an expert in the use of ultrasound for the diagnosis of musculoskeletal conditions and for guidance of injections.
Dr Grana has special interest in the area of regenerative medicine with more a decade of experience in prolotherapy, as well as several years of experience with platelet rich plasma and stem cell therapies. Dr. Grana’s extensive experience and unique set of skills set him apart as one of the premier practitioners of regenerative medicine in the country.
Knee osteoarthritis treatment with mesenchymal stem cells:
Outcome assessment comparing 3 different sources of stem cells.
The purpose of this lecture will be to present the results of our patient registry of knee osteoarthritis
patients treated with autologous mesenchymal stem cells. Three different sources of stem cells will be
compared: bone marrow aspirate (BMAC), abdominal fat, and abdominal fat with stromal vascular
fraction (SVF). Each treatment group will consist of 45-55 patients and around 70-75 knees, for a total of
> 200 knees treated. Disease severity is to be classified using knee x-rays and the Kellgren-Lawrence
grading system (Grade 0 to IV). Knee injection protocols are the same for all groups, and all treatments
performed by same physician.
Outcome measures will include numeric pain scale and Lysholm Knee Scoring Scale for function.
Measurements made at baseline, 2 months, 6 months, and one year post treatment. Pain scores,
function scores, percentage improvement, and percentage of patients undergoing knee replacement
after treatment will be presented.
This is the first time data comparing outcomes of all 3 sources of mesenchymal stem cells will be